Publications
5891 Results
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Suppl 1, p. S-478-S-479, abst. Su1673; Digestive Disease Week Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Risk factors for H. pylori recurrence one year after eradication treatment in a population randomized trial (SWOG S0701) in seven Latin American sites
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Supplement 1, p. S-465, abst. SU1618; Digestive Disease Week Annual Meeting, poster presenation;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Rome III criteria-based prevalence of dyspepsia symptoms in general populations in six countries in Latin America (SWOG trial S0701)
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Suppl 1, p. S-480; Digestive Disease Week Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Risk factors for Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)
- Journal / Conference
- Gastroenterology Vol. 142,Issue 5, Suppl 1, p. S-115-S-116; Digestive Disease Week Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Estimated one-year effectiveness and costs of six H. pylori test-and-treat strategies involving triple, concomitant or sequential drug regimens used with or without follow-up urea breath testing and rescue therapy in seven Latin American sites (SWOG trial S0701)
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Supplement 1, Pages S-183-S-184, 2012; Digestive Disease Week Annual Meeting, oral presentation;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Predictors of success of Helicobacter pylori eradication treatment in a multicentric randomized clinical trial (SWOG S0701)in Latin America
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Supplement 1, page S-113; Digestive Disease Week Annual Meeting, oral presentation, plenary session);
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Predictive markers of gemcitabine treatment response in pancreas cancer: a pharmacogenomic pathyway approach
- Journal / Conference
- Society for Clinical Trials, abstr P110, p. 153 (program booklet); poster presentation;
- Year
- 2012
- Research Committee(s)
- Multiple sites and Outcomes and Comparative Effectiveness
Provision of coverage analysis in multi-site clinical trials particularly supports smaller, community-based practices
- Journal / Conference
- Clinical Cancer Research 18(2):336-341
- Year
- 2012
- Research Committee(s)
- Melanoma
- PMID
- PMID22142824
- PMC
- PMC3422891
New challenges in endpoints for drug development in advanced melanoma [PMID22142824; PMC3422891]
- Journal / Conference
- J Clin Oncol 30(suppl; abstr e16508); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), publication only;
- Year
- 2012
- Research Committee(s)
- Multiple sites and Outcomes and Comparative Effectiveness
Strategies to increase efficiency in protocol development
- Journal / Conference
- Journal of Clinical Oncology 30 (suppl; abstr CRA6009); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), oral presentation;
- Year
- 2012
- Research Committee(s)
- Outcomes and Comparative Effectiveness